# Paolo M. Comoglio

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/paolo-m-comoglio/

## Facts

| Field | Value |
| --- | --- |
| Citations | 46,174 |
| Field | Liver physiology and pathology |
| h-index | 116 |
| i10-index | 339 |
| Last Known Institution | IFOM |
| OpenAlex ID | https://openalex.org/A5033662919 |
| ORCID iD | https://orcid.org/0000-0002-7056-5328 |
| Works | 749 |

## Researcher papers

- [Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial](https://scholariq.org/papers/dual-targeted-therapy-with-trastuzumab-and-lapatinib-in-treatment-refractory/)

## Researcher topics

- [Liver physiology and pathology](https://scholariq.org/topics/liver-physiology-and-pathology/)
- [Cancer Research and Treatments](https://scholariq.org/topics/cancer-research-and-treatments/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Fibroblast Growth Factor Research](https://scholariq.org/topics/fibroblast-growth-factor-research/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

## Researcher university

- [IFOM](https://scholariq.org/institutions/ifom/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.